Kristerpher Brimberry
Psychiatric/Mental Health · Poplar Bluff, MONPI 1871180265
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $49,380 of the $74,476 with a category attached, or 66.3%. 12 manufacturers reported payments, led by AbbVie at 57.8% of the total. Among psychiatric/mental health clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 308 payments — averaging $241.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$43K
- E.r. Squibb & Sons, L.L.C.$27K
- Alkermes, Inc.$2K
- Otsuka America Pharmaceutical, Inc.$789
- Johnson & Johnson$510
- Teva Pharmaceuticals USA, Inc.$471
- plus $889 from 6 others
What the payments were for
- Consulting fees$10,32014%
- Speaking & faculty fees$49,38066%
- Travel & lodging$7,61510%
- Food & beverage$6,9119%
- Education$2490%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 108 | $43,015 |
| E.r. Squibb & Sons, L.L.C. | 42 | $26,929 |
| Alkermes, Inc. | 73 | $1,873 |
| Otsuka America Pharmaceutical, Inc. | 14 | $789 |
| Johnson & Johnson | 11 | $510 |
| Teva Pharmaceuticals USA, Inc. | 14 | $471 |
| Neurocrine Biosciences, Inc. | 28 | $385 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $243 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $106 |
| Indivior Inc. | 4 | $89 |
| Vanda Pharmaceuticals Inc. | 3 | $50 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$41,351
- COBENFY$14,120
- LYBALVI$1,410
- ARISTADA$462
- REXULTI$358
- ABILIFY ASIMTUFII$240
- ABILIFY MAINTENA$240
- INVEGA SUSTENNA$239
- INGREZZA$134
- SPRAVATO$124
- UZEDY$123
- CAPLYTA$123
- Austedo XR$119
- ARISTADA INITIO$115
How this compares
$74,476 in reported general payments places this provider in the 95th percentile of 565 psychiatric/mental health providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 88 | $284,651 |
| VraylarCariprazine Hcl | 97 | $137,451 |
| RexultiBrexpiprazole | 44 | $67,571 |
| CaplytaLumateperone Tosylate | 16 | $27,507 |
| TrintellixVortioxetine Hydrobromide | 33 | $21,163 |
| Chlorpromazine Hcl | 42 | $13,167 |
| Lurasidone Hcl | 76 | $9,974 |
| Paliperidone ErPaliperidone | 82 | $9,851 |
| Aripiprazole | 191 | $9,087 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 75 | $7,306 |
| Trazodone Hcl | 373 | $6,413 |
| Hydroxyzine Pamoate | 230 | $4,492 |
| Duloxetine Hcl | 178 | $4,253 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 125 | $3,653 |
| Olanzapine | 122 | $2,994 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $510 | $284,65188 claims |
| AbbVieVraylar | $43,015 | $137,45197 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $789 | $67,57144 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $243 | $27,50716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 565 psychiatric/mental health providers in Missouri.
Other psychiatric/mental health in Poplar Bluff
- Camellia VermillionPoplar Bluff$6K
- Aldijana SacicSaint Louis$510K
- Erin DuvallSpringfield$275K
- Laurel OwensLees Summit$246K
- Julie WaterburySaint Louis$135K
- Emily WoukSpringfield$90K
- Matthew LindquistSt Louis$42K
- Stacy EmersonKennett$25K
- Jeffery DavisCreve Coeur$24K
- Kelsey KingsboroughMexico$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.